Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Frontiers in Cardiovascular Medicine|October 3, 2022
Determinants of the time-to-peak left ventricular dP/dt (Td) and QRS duration with different fusion strategies in cardiac resynchronization therapyHans Henrik Odland, Torbjørn Holm, Richard Cornelussen, et al.
Heart Rhythm|May 2, 2016
Focal impulse and rotor modulation as a stand-alone procedure for the treatment of paroxysmal atrial fibrillation: A within-patient controlled study with implanted cardiac monitoringRolf Franck Berntsen, Trine Fink Håland, Rita Skårdal, et al.
Ugeskrift for Laeger|April 6, 2011
[Treatment of local recurrence of rectal cancer]Michael Solomon, Kirk Austin, Peter Lee, et al.
Open Heart|May 8, 2021
Determinants of LV dP/dtmax and QRS duration with different fusion strategies in cardiac resynchronisation therapyHans Henrik Odland, Torbjørn Holm, Lars Ove Gammelsrud, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 16, 2002
Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjectsKirsten B Holven, Pål Aukrust, Torbjørn Holm, et al.
The British Journal of Nutrition|March 12, 2003
Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjectsKirsten B Holven, Tor S Haugstad, Torbjørn Holm, et al.
ESC Heart Failure|September 13, 2021
Shortening of time-to-peak left ventricular pressure rise (Td) in cardiac resynchronization therapyHans Henrik Odland, Manuel Villegas-Martinez, Stian Ross, et al.
Transplantation|May 24, 2007
Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantationSatish Arora, Lars Gullestad, Ragnhild Wergeland, et al.
Cardiovascular Research|June 14, 2002
Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failureArne Yndestad, Jan Kristian Damås, Hans Geir Eiken, et al.
Clinical Cardiology|May 4, 2004
Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammationAina Hognestad, Pål Aukrust, Ragnhild Wergeland, et al.
Pageof 2